期刊文献+

胰岛素制剂及应用研究进展 被引量:3

Progress of insulin preparation and application
原文传递
导出
摘要 胰岛素类似物、吸人胰岛素、黏膜吸收胰岛素等新型胰岛素剂型和给药方式的研究,有助于减少或避免频繁的注射给药和更好地控制血糖。由于胰岛素口服或腹腔给药能模拟生理条件下胰岛素门脉系统传输过程,产生肝脏高于外周的胰岛素浓度差,更符合生理条件,因此研制口服胰岛素制剂和腹腔胰岛素给药系统仍是十分必要的,这对防止糖尿病并发症的发生具有重要意义。对多种胰岛素制剂和给药方法的研究进展进行了简要综述。 The developments of new insulin preparations such as insulin analog, inhaled insulin, mucosal insulin delivery systems, and routes of insulin administration, are helpful to reduce or avoid repeated injections and provide more benefits in blood glucose control. Since the oral and intraperitoneal routes of insulin administration can mimic the physiological portal rout of insulin delivery, which is associated with greater hepatic concentration/peripheral concentration ratio,development of new oral and intraperitoneal insulin delivery systems are required to improve glucose and lipid metabolism and lower the risk of diabetes complications. This article is going to review the recent advances in the related studies.
作者 相莉 孙洪范
出处 《国际生物医学工程杂志》 CAS 2007年第4期236-239,共4页 International Journal of Biomedical Engineering
关键词 胰岛素类似物 口服胰岛素 吸入胰岛素 胰岛素泵 糖尿病 insulin analog oral insulin inhaled insulin insulin pump diabetes
  • 相关文献

参考文献29

  • 1Raccah D, Bretzel RG, Owens D, et al. When basal insulin therapy in type 2 diabetes mellitus is not enough-what next?[J]. Diabetes Metab Res Rev, 2007, 23(4): 257-264.
  • 2Cough SC. A review of human and analogue insulin trials [J]. Diabetes Res Clin Pract, 2007, 77(1): 1-15.
  • 3Kamal AD, Bain SC. Insulin glulisine: Efficacy and safety compared with other rapid-acting insulin analogues[J]. Expert Opin Drug Saf, 2007, 6(1): 5-7.
  • 4Kamal AD, Dixon AN, Bain SC. Safety and side effects of the insulin analogues[J]. Expert Opin Drug Saf, 2006, 5(1): 131-143.
  • 5Chlup R, Zapletalova J, Seckar P, et al. Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 diabetes treated by means of an insulin pump [J]. Biomed Pap Med Fac Univ palacky Olomouc Czech Repub, 2004, 148(1): 27-32.
  • 6Barnett AH. Insulin glargine in the treatment of type 1 and type 2 diabetes[J]. Vasc Health Risk Manag, 2006, 2(1): 59-67.
  • 7Colquitt JL, Green C, Sidhu MK, et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes [J ]. Health Technol Assess, 2004, 8(43): 1-171.
  • 8Kisel MA, Kulik LN, Tsybovsky IS, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: Studies in the rat[J]. Int J Pharm, 2001, 216(1-2): 105-114.
  • 9Iwanaga K, Ono S, Narioka K, et al. Application of surface-coated liposomes for oral delivery of peptide: Effects of coating the liposome's surface on the GI transit of insulin [J]. J Pharm Sci, 1999, 88(2): 248-252.
  • 10Morishita M, Goto T, Nakamura K, et al. Novel oral insulin delivery systems based on complexation polymer hydrogels: Single and multiple administration studies in type 1 and 2 diabetic rats[J]. J Control Rel, 2006, 110(3): 587-594.

二级参考文献9

  • 1Durra C, Curran MP. Inhaled human insulin ( Exubera ) : a review of its use in adult patients with diabetes mellitus. Drugs,2006, 66:1013-1032.
  • 2Patton JS, Bukar JG, Eldon MA. Clinical pharmacokinetics and pharmacodynamica of inhaled insulin. Clin Pharmacokinet, 2004,43 : 781-801.
  • 3Scholtz HE, Pretorius SG, Wessels DH, et al. Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia, 2005,48 : 1988-1995.
  • 4Kapitza C, Hompesch M, Scharling B, et al. Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin. Diabetes Technol Ther,2004, 6: 466-472.
  • 5Quattrin T, Belanger A, Bohannon NJV, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes, results of a 6-month,randomized, comparative trial. Diabetes Care,2004, 27:2622-2627.
  • 6潘妍,徐晖,赵会英,魏刚,郑俊民.胰岛素乳酸/羟基乙酸共聚物纳米粒的制备及口服药效学研究[J].药学学报,2002,37(5):374-377. 被引量:27
  • 7陈西敬,朱家壁,王广基,周明霞,辛芙萌,张娜,王成蹊,徐越宁.胰岛素粉雾剂肺部给药对大鼠的降血糖作用(英文)[J].Acta Pharmacologica Sinica,2002,23(5):467-470. 被引量:3
  • 8左晓春,张杰,彭健.非注射胰岛素制剂的研究进展[J].中国临床药理学杂志,2003,19(2):149-150. 被引量:2
  • 9余叶蓉,李宏亮,喻红玲,王椿,蒲素.单纯性肥胖患者胰岛素抵抗与内皮依赖性血管舒张功能的研究[J].中华医学杂志,2003,83(17):1467-1470. 被引量:23

共引文献25

同被引文献19

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部